All News Energy News Space

Urinary Incontinence Market Insights, Treatment and Market Growth by DelveInsight

DelveInsight has launched a new report on Urinary Incontinence Market

Urinary incontinence, which is also known as the loss of bladder control is a common problem in which a person leaks urine by chance. Although, it may happen to anyone but older people specially women are severely affected by this problem. Urinary incontinence is not just a health problem, it can affect emotional, psychological and social life. Many people who have urinary incontinence are anxious to do normal daily events. They do not want to be too distant from a toilet. Urinary incontinence can keep people from enjoying life.

DelveInsight’s “Urinary Incontinence Market Insights, Epidemiology and Market Forecast—2030” report provides an overview of the disease and market size of for the seven major pharmaceutical markets, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. This report covers the various treatment practices, and Urinary Incontinence forecasted epidemiology from 2020 to 2030, segmented by the seven major markets.

Get a Urinary Incontinence market report sample page-

Urinary Incontinence Market Overview

Urinary incontinence types include stress incontinence, urge incontinence, and overflow incontinence, functional incontinence, and mixed incontinence. Urinary incontinence is not a disease, it is a symptom. It can be caused by everyday habits, underlying medical conditions or physical problems. Certain drinks, foods, and medications may act as diuretics which stimulates the individual’s bladder; increasing the volume of urine.

They include alcohol, caffeine, carbonated drinks, sparkling water, artificial sweeteners, chocolate, and large doses of vitamin C, among others. It may also be caused by some easily treatable medical conditions, such as first urinary tract infection which can irritate the person’s bladder and cause strong urge to urinate. And, constipation in this condition hardens, compacts stool in the individual’s rectum, causing the nerves to be overactive and increasing the urinary frequency.

Urinary Incontinence Treatment

Urinary Incontinence market is segmented into behavioral techniques, muscle exercises, electrical stimulation, medications, and interventional therapies, among others. However, treatment for urinary incontinence depends on the type of incontinence, its severity, and the underlying cause. The therapeutic modalities have been designed based on a better understanding of the pathogenesis of Urinary Incontinence.

For the treatment of urinary incontinence, doctors might suggest behavioral techniques, such as bladder training to delay the urination, double voiding to empty the patient’s bladder completely, scheduling of toilet trips, and fluid and diet management, among others. In muscle exercises, doctors recommend exercises of tightening (contract) of the muscles, person would use to stop urinating and hold for 5 s, and then relax for 5

Urinary Incontinence Key Strengths

  • 11 Year Forecast
  • 7MM Coverage
  • Epidemiology Segmentation
  • Drugs Uptake
  • Highly Analyzed Market
  • Key Cross Competition
  • Urinary Incontinence Market Size by Country
  • Urinary Incontinence Market Size by Therapy

Urinary Incontinence Market Outlook

The current therapeutic market of Urinary Incontinence is dependent on both the marketed as well as generic products. Some of the common medications used to treat urinary incontinence include anticholinergics which include oxybutynin (Ditropan XL), tolterodine (Detrol), darifenacin (Enablex), fesoterodine (Toviaz), solifenacin (Vesicare), and trospium (Sanctura). Additionally, Mirabegron (Myrbetriq) which is used to treat urge incontinence relaxes the bladder muscle and can increase the amount of urine individual’s bladder can hold. Also, the alpha-blocker includes tamsulosin (Flomax), alfuzosin (Uroxatral), silodosin (Rapaflo), doxazosin (Cardura) and terazosin, and topical estrogen. In some cases, interventional therapies can also be used which include bulking material injection, botulinum toxin type A (Botox), and nerve stimulators. In bulking material injections, a synthetic material is injected into tissue surrounding the urethra.

This material helps in keeping the urethra closed and reduce urine leakage. Botox is usuallyprescribed to people only if other first-line medications have not been efficacious. Nerve stimulators devices resembles with a pacemaker and is implanted under the patients’ skin to deliver painless electrical pulses to the nerves which are involved in bladder control. Thus, there are many therapies that are being used for the management of Urinary Incontinence, yet they often cause some side effects. The market is in urgent need of a potential drug that ideally would target all of the pathogenic mechanisms involved in Urinary Incontinence without systemic side effects.

Key companies of the report

  • ALZA Corporation
  • Pfizer
  • Astellas Pharma
  • And many others

Get a Urinary Incontinence market report sample page-

Table of content

  1. Key Insights
  2. Executive Summary of Urinary Incontinence
  3. Competitive Intelligence Analysis for Urinary Incontinence
  4. Urinary Incontinence: Market Overview at a Glance
  5. Urinary Incontinence: Disease Background and Overview
  6. Patient Journey
  7. Urinary Incontinence Epidemiology and Patient Population
  8. Treatment Algorithm, Current Treatment, and Medical Practices
  9. Unmet Needs
  10. Key Endpoints of Urinary Incontinence Treatment
  11. Marketed Products
  12. Emerging Therapies
  13. Urinary Incontinence: Seven Major Market Analysis
  14. Attribute analysis
  15. 7MM: Market Outlook
  16. Access and Reimbursement Overview of Urinary Incontinence
  17. KOL Views
  18. Market Drivers
  19. Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer
  23. About DelveInsight

 Why should you buy this report?

  • The report will help in creating business methodologies by understanding patterns forming and driving the Urinary Incontinence market
  • To comprehend the future market rivalry in the Urinary Incontinence market and Insightful survey of the key market drivers and hindrances
  • Sort out deals and promoting endeavors by recognizing the best open doors for Urinary Incontinence in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • ID of solid impending parts in the market will help in formulating procedures that will help in advancing beyond contenders
  • Coordinate deals and showcasing endeavors by recognizing the best open doors for Urinary Incontinence market
  • To comprehend the future market rivalry in the Urinary Incontinence market

You can check other related reports-

Check latest blogs–

Contact us

Shruti Thakur

[email protected]


LinkedIn | Facebook | Twitter